Horizon Therapeutics Pub L Stock Price, News & Analysis

HZNP NASDAQ

Company Description

Horizon Therapeutics Pub L (NASDAQ: HZNP) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

HZNP stock has declined 100.0% over the past year.

This page provides a comprehensive overview of HZNP stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

229.0M

Shares outstanding

Horizon Therapeutics Pub L (HZNP) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

October 6, 2023

0.00%

Rule 17(e) Announcement - Horizon Therapeutics plc

October 5, 2023

+0.04%

Rule 17(d) Announcement – Horizon Therapeutics plc

October 3, 2023

+0.26%

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

October 2, 2023

+0.21%

Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023

September 29, 2023

0.00%

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

September 29, 2023

0.00%

New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes

Horizon Therapeutics Pub L has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial. View all HZNP news →

SEC Filings

View All

No SEC filings available for HZNP.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

HZNP Company Profile & Sector Positioning

Horizon Therapeutics Pub L (HZNP) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.